Skip to main content
Equibles

LSV ASSET MANAGEMENT

Position in PBYI — Puma Biotechnology, Inc.

CIK 1050470 CHICAGO, IL
Back to PBYI Full portfolio

Position in PBYI

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$13,121,825
+$5,563,299 QoQ
Shares Held
1,617,981
+36.8% QoQ
Ownership
3.13%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#8
of 160 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority Sole 70% Shared 0% None 30%

Common Shares in PBYI Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

LSV ASSET MANAGEMENT holds $1,914,392,782 across 14 Biotechnology names. PBYI ranks #10 (0.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 JAZZ
Jazz Pharmaceuticals plc
 2,275,145 $548,241,690
2 INCY
Incyte Corp
 4,123,759 $467,469,320
3 EXEL
Exelixis, Inc.
 8,146,478 $443,249,867
4 REGN
Regeneron Pharmaceuticals, Inc.
 253,200 $157,880,328
5 HALO
Halozyme Therapeutics, Inc.
 1,410,257 $110,380,815
6 HRMY
Harmony Biosciences Holdings, Inc.
 2,061,242 $75,049,821
7 BMRN
Biomarin Pharmaceutical Inc
 881,700 $50,450,874
8 RIGL
Rigel Pharmaceuticals Inc
 721,666 $28,231,573

All Filings in PBYI

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $13,121,825 1,617,981
2026-03-31 $7,558,526 1,182,868
2025-12-31 $2,408,571 404,802
2025-09-30 $2,973,180 559,921
2025-06-30 $1,837,588 535,740
2025-03-31 $158,064 53,400
2024-12-31 $162,870 53,400
2024-09-30 $77,520 30,400
2024-06-30 $99,104 30,400
2024-03-31 $161,120 30,400
2023-12-31 $375,198 86,651
2023-09-30 $227,892 86,651
2023-06-30 $686,765 194,551
2023-03-31 $601,162 194,551
2022-12-31 $850,868 201,151
2022-09-30 $431,574 182,099